What Happened: Anand's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, involves purchasing 1,819 shares of Agilent Technologies. The total ...

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that FIELDS purchased 1,819 shares of Agilent Technologies. The total transaction amounted to $220,426 ...

Valued at a market cap of $34.5 billion, Agilent Technologies, Inc. (A) is an original equipment manufacturer of a ...

This was the stock's fourth consecutive day of losses.

Agilent Technologies, with a 10-year CAGR of 13.6% and strong financials, is a must-watch after its post-earnings dip. Read more on A stock here.

Life sciences tools company Agilent Technologies (NYSE:A) in Q4 CY2024, with sales up 1.4% year on year to $1.68 billion. On the other hand, next quarter’s revenue guidance of $1.63 billion was less ...

Revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% on a core (1) basis compared with the first quarter of 2024. GAAP net income of ...

The company reported $1.68 billion in revenue at a 25.1% operating margin across its businesses in America, Europe, and Asia.

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic ...

At this time, I would like to welcome everyone to the First Quarter 2025 Agilent Technologies Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

Technologies announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU ...